|
Volumn 299, Issue 5613, 2003, Pages 1646-1649
|
The medication merry-go-round
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHETAMINE DERIVATIVE;
ANTIDEPRESSANT AGENT;
ATOMOXETINE;
BUSPIRONE;
CENTRAL STIMULANT AGENT;
CHLORPROMAZINE;
CLOMIPRAMINE;
CLONIDINE;
DESIPRAMINE;
DOXEPIN;
FLUOXETINE;
FLUVOXAMINE;
FLUVOXAMINE MALEATE;
HALOPERIDOL;
LITHIUM;
METHYLPHENIDATE;
NEUROLEPTIC AGENT;
PAROXETINE;
PEMOLINE;
PIMOZIDE;
RISPERIDONE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
TRICYCLIC ANTIDEPRESSANT AGENT;
TRIFLUOPERAZINE;
PSYCHOTROPIC AGENT;
MEDICINE;
ANXIETY DISORDER;
APPETITE DISORDER;
ATTENTION DEFICIT DISORDER;
BEHAVIOR DISORDER;
BEHAVIOR THERAPY;
BIPOLAR DISORDER;
CHILD PSYCHIATRY;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG BLOOD LEVEL;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG LABELING;
DRUG MARKETING;
DRUG RESEARCH;
DRUG UTILIZATION;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
GILLES DE LA TOURETTE SYNDROME;
HEALTH MAINTENANCE ORGANIZATION;
HEALTH PROGRAM;
HUMAN;
MEDICAL SOCIETY;
NUTRITIONAL DISORDER;
PRESCRIPTION;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
PSYCHOSIS;
REVIEW;
RISK ASSESSMENT;
SCHIZOPHRENIA;
WEIGHT GAIN;
ADULT;
AGING;
ANIMAL;
ARTICLE;
BRAIN;
CHILD;
DRUG LEGISLATION;
DRUG SCREENING;
MENTAL DISEASE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATENT;
PATHOLOGY;
PHASE 4 CLINICAL TRIAL;
PSYCHOPHARMACOLOGY;
UNITED STATES;
ADULT;
AGING;
ANIMALS;
BRAIN;
CHILD;
CLINICAL TRIALS;
CLINICAL TRIALS, PHASE IV;
DRUG EVALUATION, PRECLINICAL;
DRUG LABELING;
DRUG UTILIZATION;
HUMANS;
LEGISLATION, DRUG;
MAGNETIC RESONANCE IMAGING;
MENTAL DISORDERS;
PATENTS;
PSYCHOPHARMACOLOGY;
PSYCHOTROPIC DRUGS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 0037436682
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.299.5613.1646 Document Type: Review |
Times cited : (3)
|
References (0)
|